The development and assessment of both a separate, once-daily modified release matrix formulation of metoprolol tartrate and a combination formulation with hydrochlorothiazide
The use of controlled release dosage forms has increased significantly in recent years as they result in increased patient compliance and higher therapeutic efficiency. This research focused on the development of a once daily dosage form that could be used for the treatment of hypertension. Both a s...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
Rhodes University
2001
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10962/d1003220 |